Pharmacists: Leading the Way in Diabetes Care with Continuous Glucose Monitors
Diabetes is a pressing health concern in the United States, and projected numbers paint a concerning picture. By 2030, over 54.9 million Americans are expected to be living with the disease. This surge underscores the urgent need for innovative prevention strategies and cutting-edge management tools. Thankfully, continuous glucose monitors (CGMs) are emerging as game-changers, transforming diabetes care with their real-time insights into blood sugar levels.
CGMs offer a vast improvement over traditional finger-prick methods, providing a continuous stream of data that reveals patterns and fluctuations in glucose levels. This granularity empowers patients and healthcare providers to make informed decisions about medication, diet, and lifestyle choices, ultimately leading to better glycemic control and reduced risk of long-term complications.
While CGM technology is continuously advancing, pharmacists are playing a crucial role in bridging the gap between this sophisticated technology and its intended users. Their unique position within the healthcare landscape places them at the forefront of patient education, medication expertise, and accessibility.
"Pharmacists have a huge opportunity to educate the public about CGMs and their potential benefits," says Heather Folz, PharmD, BCACP, an associate professor of pharmacy practice and ambulatory care clinical pharmacist at MedStar Franklin Square Medical Center. “They can guide patients through the use of these devices, explain how to interpret the data, and address any anxieties they might have."
However, integrating CGMs into diabetes care plans presents certain challenges. Christina H. Sherrill, PharmD, BCACP, BC-ADM, an associate professor at UNC Eshelman School of Pharmacy, highlights that "billing and reimbursement complexities can be a major hurdle. Time constraints within busy pharmacies can also limit pharmacists’ ability to provide comprehensive patient education on these new technologies."
Overcoming these hurdles requires a multi-pronged approach. Comprehensive training programs for pharmacists and pharmacy students are essential to ensure they feel confident and knowledgeable about CGM technology. Furthermore, advocating for streamlined billing and reimbursement policies will encourage wider adoption of these valuable services.
"We need to start early, incorporating CGM education into pharmacy curricula," says Sherrill. "This will help address the training gap and equip future pharmacists to confidently address the increasing demand for CGM services."
The increasing availability of over-the-counter CGMs further amplifies the role pharmacists play. They are uniquely positioned to guide patients through informed decision-making about their diabetes management, ensuring they understand the benefits and potential drawbacks of different devices and choose the one that best suits their needs.
Looking ahead, the future of diabetes care hinges on collaboration and innovation. Pharmacists, with their patient-centric approach and expertise, are poised to become key drivers of positive change. As CGMs become even more integrated into diabetes management, pharmacists will undoubtedly continue to evolve their roles, empowering individuals to take control of their health and live fuller, healthier lives.